Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
480 INR | +1.66% | -4.12% | +1.77% |
Mar. 27 | Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading | MT |
Mar. 26 | Wipro GE Healthcare to invest $960 mln in R&D, manufacturing in India | RE |
Sales 2024 * | 899B 10.78B | Sales 2025 * | 944B 11.33B | Capitalization | 2,464B 29.56B |
---|---|---|---|---|---|
Net income 2024 * | 111B 1.33B | Net income 2025 * | 124B 1.48B | EV / Sales 2024 * | 2.47 x |
Net cash position 2024 * | 245B 2.94B | Net cash position 2025 * | 331B 3.97B | EV / Sales 2025 * | 2.26 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
20.2
x | Employees | 250,000 |
Yield 2024 * |
0.74% | Yield 2025 * |
1.94% | Free-Float | 26.67% |
Latest transcript on Wipro Limited
1 day | +1.55% | ||
1 week | -4.23% | ||
Current month | -7.64% | ||
1 month | -7.27% | ||
3 months | +2.20% | ||
6 months | +18.16% | ||
Current year | +1.65% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 20-07-05 | |
Chairman | 47 | 07-07-19 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Ennis
BRD | Director/Board Member | 61 | 16-03-31 |
Director/Board Member | 78 | 66-08-16 | |
Chief Executive Officer | 56 | 20-07-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 480 | +1.66% | 234 609 |
24-03-27 | 472.2 | -1.57% | 260,004 |
24-03-26 | 479.8 | -1.50% | 194,127 |
24-03-22 | 487 | -2.73% | 842,058 |
24-03-21 | 500.7 | +1.44% | 361,134 |
Delayed Quote Bombay S.E., March 28, 2024 at 05:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.65% | 29.57B | |
-2.84% | 214B | |
+16.66% | 175B | |
+2.51% | 167B | |
+6.59% | 102B | |
+10.77% | 81.08B | |
+26.21% | 77.94B | |
-2.61% | 73.72B | |
-19.58% | 53.45B | |
+5.68% | 50.25B |